Record details

This document is also available in the following languages:

General Information

Country

Germany

Title of risk assessment

6786-01-0213 (adv. 42010.0213); Summary of the risk assessment of a deliberate release (field trial) of genetically modified Rhodococcus equi RG2837, issued by the German Competent Authority

Date of the risk assessment

2012-06-04

Competent National Authority(ies) responsible for the risk assessment

Record #12096

Federal Office of Consumer Protection and Food Safety

Mauerstrasse 39-42

Berlin

Germany, 10117

Phone:	+49-(0)3018-445-6500
Fax:	+49-(0)3018-445-6099
Email:	german_bch@bvl.bund.de
Url:	http://www.biosafety-bch.de (english language),BVL Homepage (English)

Risk assessment details

Living modified organism

Record #107877

Rhodococcus equi Vaccine

Intervet Resistance to diseases and pests - Bacteria

Scope of the risk assessment

LMOs for Introduction into the environment
- Field trial

Risk assessment report / Summary

6786-01-0213 (adv. 42010.0213); Summary of the risk assessment of a deliberate release (field trial) of genetically modified Rhodococcus equi RG2837, issued by the German Competent Authority (courtesy translation; only the German text is authentic)

6786-01-0213 (bzw. 42010.0213); Zusammenfassung der Risikobewertung eines Freisetzungsvorhabens (Feldversuch) mit gentechnisch verändertem Rhodococcus equi RG2837, erstellt durch die deutsche zuständige Behörde

Methodology and points to consider

Potential adverse effects identified in the risk assessment

The execution of this field trial is not expected to have a negative impact on human or animal health, or on the environment.

Estimation of the overall risk

Adverse effects on human or animal health or on the environment are not expected.

Receiving environment(s) considered

One field site in Germany, for details refer to the German LMO/GMO location register ( http://apps2.bvl.bund.de/stareg_web/localeSwitch.do?language=en&page=/showflaechen.do?)

Additional Information

deliberate release, no placing on the market.
animal experiment for vaccine design
publication:
Bargen and Haas (2009) Molecular and infection biology of the horse pathogen Rhodococcus equi, FEMS Microbiol Rev, 33: 870-891

Other relevant website address or attached documents

EN		BVL database on field trials in Germany (German language only)
DE		BVL-Datenbank zu Freisetzungsvorhaben in Deutschland

EN		BVL German LMO/GMO location register
DE		Deutsches GVO-Standortregister des BVL

EN		Summary Notification Information Format available on the Internet (WebSNIF)
DE		Summary Notification Information Format erhältlich im Internet (WebSNIF) (nur in englischer Sprache)